| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154567 | American Heart Journal | 2005 | 7 Pages |
Abstract
Diabetes is a consistent clinical predictor of cardiovascular complications and fluvastatin reduces the increased incidence of long-term adverse complications associated with the presence of diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chourmouzios A. MD, PhD, Dick MSc, Patrick W. MD, PhD, Francesco MD, PhD, Pedro A. MD, PhD, Pim MD, PhD, on behalf of the LIPS Investigators on behalf of the LIPS Investigators,